Laura Loiacono

Statistics

Publications

Citations

685

H-Index

Active since

1997

Affiliations

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani(Current)

Ospedale Papa Giovanni XXIII

Istituti di Ricovero e Cura a Carattere Scientifico

University of Naples Federico II

University of Pisa

Laura Loiacono is an author at Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani specializing in infectious diseases, virology, and antiviral therapy.

Publications per year

1997–2021

Publications

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy

Vincenzo Guadagnino, Tommaso Stroffolini, M. Rapicetta et al. · Hepatology · 1997 · 383 citations

Life Sciences, Infectious Diseases, Microbiology +13

Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection

Robert J. Fontana, Robert S. Brown, Ana Moreno‐Zamora et al. · Liver Transplantation · 2016 · 78 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital

Annalisa Mondi, Patrizia Lorenzini, Concetta Castilletti et al. · International Journal of Infectious Diseases · 2021 · 49 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Hepatitis C virus infection in family setting

Vincenzo Guadagnino, Tommaso Stroffolini, Alfredo Focà et al. · European Journal of Epidemiology · 1998 · 31 citations

Veterinary Medicine, Family Medicine, Infectious Diseases +10

Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post‐transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study

Raffaella Lionetti, Vincenza Calvaruso, Paola Piccolo et al. · Clinical Transplantation · 2017 · 24 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

1–5 of 13